Literature DB >> 23535823

A sequence variant associated with sortilin-1 (SORT1) on 1p13.3 is independently associated with abdominal aortic aneurysm.

Gregory T Jones1, Matthew J Bown, Solveig Gretarsdottir, Simon P R Romaine, Anna Helgadottir, Grace Yu, Gerard Tromp, Paul E Norman, Cao Jin, Annette F Baas, Jan D Blankensteijn, Iftikhar J Kullo, L Victoria Phillips, Michael J A Williams, Ruth Topless, Tony R Merriman, Thodor M Vasudevan, David R Lewis, Ross D Blair, Andrew A Hill, Robert D Sayers, Janet T Powell, Panagiotis Deloukas, Gudmar Thorleifsson, Stefan E Matthiasson, Unnur Thorsteinsdottir, Jonathan Golledge, Robert A Ariëns, Anne Johnson, Soroush Sohrabi, D Julian Scott, David J Carey, Robert Erdman, James R Elmore, Helena Kuivaniemi, Nilesh J Samani, Kari Stefansson, Andre M van Rij.   

Abstract

Abdominal aortic aneurysm (AAA) is a common human disease with a high estimated heritability (0.7); however, only a small number of associated genetic loci have been reported to date. In contrast, over 100 loci have now been reproducibly associated with either blood lipid profile and/or coronary artery disease (CAD) (both risk factors for AAA) in large-scale meta-analyses. This study employed a staged design to investigate whether the loci for these two phenotypes are also associated with AAA. Validated CAD and dyslipidaemia loci underwent screening using the Otago AAA genome-wide association data set. Putative associations underwent staged secondary validation in 10 additional cohorts. A novel association between the SORT1 (1p13.3) locus and AAA was identified. The rs599839 G allele, which has been previously associated with both dyslipidaemia and CAD, reached genome-wide significance in 11 combined independent cohorts (meta-analysis with 7048 AAA cases and 75 976 controls: G allele OR 0.81, 95% CI 0.76-0.85, P = 7.2 × 10(-14)). Modelling for confounding interactions of concurrent dyslipidaemia, heart disease and other risk factors suggested that this marker is an independent predictor of AAA susceptibility. In conclusion, a genetic marker associated with cardiovascular risk factors, and in particular concurrent vascular disease, appeared to independently contribute to susceptibility for AAA. Given the potential genetic overlap between risk factor and disease phenotypes, the use of well-characterized case-control cohorts allowing for modelling of cardiovascular disease risk confounders will be an important component in the future discovery of genetic markers for conditions such as AAA.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23535823      PMCID: PMC3690970          DOI: 10.1093/hmg/ddt141

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  20 in total

1.  Association between serum lipoproteins and abdominal aortic aneurysm.

Authors:  Jonathan Golledge; Frank van Bockxmeer; Konrad Jamrozik; Moira McCann; Paul E Norman
Journal:  Am J Cardiol       Date:  2010-03-30       Impact factor: 2.778

2.  The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm.

Authors:  Anna Helgadottir; Gudmar Thorleifsson; Kristinn P Magnusson; Solveig Grétarsdottir; Valgerdur Steinthorsdottir; Andrei Manolescu; Gregory T Jones; Gabriel J E Rinkel; Jan D Blankensteijn; Antti Ronkainen; Juha E Jääskeläinen; Yoshiki Kyo; Guy M Lenk; Natzi Sakalihasan; Konstantinos Kostulas; Anders Gottsäter; Andrea Flex; Hreinn Stefansson; Torben Hansen; Gitte Andersen; Shantel Weinsheimer; Knut Borch-Johnsen; Torben Jorgensen; Svati H Shah; Arshed A Quyyumi; Christopher B Granger; Muredach P Reilly; Harland Austin; Allan I Levey; Viola Vaccarino; Ebba Palsdottir; G Bragi Walters; Thorbjorg Jonsdottir; Steinunn Snorradottir; Dana Magnusdottir; Gudmundur Gudmundsson; Robert E Ferrell; Sigurlaug Sveinbjornsdottir; Juha Hernesniemi; Mika Niemelä; Raymond Limet; Karl Andersen; Gunnar Sigurdsson; Rafn Benediktsson; Eric L G Verhoeven; Joep A W Teijink; Diederick E Grobbee; Daniel J Rader; David A Collier; Oluf Pedersen; Roberto Pola; Jan Hillert; Bengt Lindblad; Einar M Valdimarsson; Hulda B Magnadottir; Cisca Wijmenga; Gerard Tromp; Annette F Baas; Ynte M Ruigrok; Andre M van Rij; Helena Kuivaniemi; Janet T Powell; Stefan E Matthiasson; Jeffrey R Gulcher; Gudmundur Thorgeirsson; Augustine Kong; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  Nat Genet       Date:  2008-01-06       Impact factor: 38.330

3.  Identification of a genetic variant associated with abdominal aortic aneurysms on chromosome 3p12.3 by genome wide association.

Authors:  James R Elmore; Melissa A Obmann; Helena Kuivaniemi; Gerard Tromp; Glenn S Gerhard; David P Franklin; Amy M Boddy; David J Carey
Journal:  J Vasc Surg       Date:  2009-06       Impact factor: 4.268

4.  The aneurysm detection and management study screening program: validation cohort and final results. Aneurysm Detection and Management Veterans Affairs Cooperative Study Investigators.

Authors:  F A Lederle; G R Johnson; S E Wilson; E P Chute; R J Hye; M S Makaroun; G W Barone; D Bandyk; G L Moneta; R G Makhoul
Journal:  Arch Intern Med       Date:  2000-05-22

5.  Atherosclerosis in abdominal aortic aneurysms: a causal event or a process running in parallel? The Tromsø study.

Authors:  Stein Harald Johnsen; Signe Helene Forsdahl; Kulbir Singh; Bjarne Koster Jacobsen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-04-01       Impact factor: 8.311

6.  Effect of hypertension and risk factors on diameters of abdominal aorta and common iliac and femoral arteries in middle-aged hypertensive and control subjects: a cross-sectional systematic study with duplex ultrasound.

Authors:  M J Päivänsalo; J Merikanto; T Jerkkola; M J Savolainen; A O Rantala; H Kauma; M Lilja; A Reunanen Y; A Kesäniemi; I Suramo
Journal:  Atherosclerosis       Date:  2000-11       Impact factor: 5.162

Review 7.  Abdominal aortic aneurysm.

Authors:  N Sakalihasan; R Limet; O D Defawe
Journal:  Lancet       Date:  2005 Apr 30-May 6       Impact factor: 79.321

8.  Genetic variation at chromosome 1p13.3 affects sortilin mRNA expression, cellular LDL-uptake and serum LDL levels which translates to the risk of coronary artery disease.

Authors:  Patrick Linsel-Nitschke; Jörg Heeren; Zouhair Aherrahrou; Petra Bruse; Christian Gieger; Thomas Illig; Holger Prokisch; Katharina Heim; Angela Doering; Annette Peters; Thomas Meitinger; H-Erich Wichmann; Anke Hinney; Thomas Reinehr; Christian Roth; Jan R Ortlepp; Mouhidien Soufi; Alexander M Sattler; Jürgen Schaefer; Klaus Stark; Christian Hengstenberg; Arne Schaefer; Stefan Schreiber; Florian Kronenberg; Nilesh J Samani; Heribert Schunkert; Jeanette Erdmann
Journal:  Atherosclerosis       Date:  2009-07-08       Impact factor: 5.162

9.  Association of the single nucleotide polymorphism rs599839 in the vicinity of the sortilin 1 gene with LDL and triglyceride metabolism, coronary heart disease and myocardial infarction. The Ludwigshafen Risk and Cardiovascular Health Study.

Authors:  Marcus E Kleber; Wilfried Renner; Tanja B Grammer; Patrick Linsel-Nitschke; Bernhard O Boehm; Bernhard R Winkelmann; Peter Bugert; Michael M Hoffmann; Winfried März
Journal:  Atherosclerosis       Date:  2009-10-02       Impact factor: 5.162

Review 10.  Circulating markers of abdominal aortic aneurysm presence and progression.

Authors:  Jonathan Golledge; Philip S Tsao; Ronald L Dalman; Paul E Norman
Journal:  Circulation       Date:  2008-12-02       Impact factor: 29.690

View more
  44 in total

Review 1.  Understanding the pathogenesis of abdominal aortic aneurysms.

Authors:  Helena Kuivaniemi; Evan J Ryer; James R Elmore; Gerard Tromp
Journal:  Expert Rev Cardiovasc Ther       Date:  2015

2.  Identification of Genetic Variants Linking Protein C and Lipoprotein Metabolism: The ARIC Study (Atherosclerosis Risk in Communities).

Authors:  James S Pankow; Weihong Tang; Nathan Pankratz; Weihua Guan; Lu-Chen Weng; Mary Cushman; Eric Boerwinkle; Aaron R Folsom
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-01-12       Impact factor: 8.311

Review 3.  Genome-wide association studies of late-onset cardiovascular disease.

Authors:  J Gustav Smith; Christopher Newton-Cheh
Journal:  J Mol Cell Cardiol       Date:  2015-04-11       Impact factor: 5.000

4.  Genetic risk models: Influence of model size on risk estimates and precision.

Authors:  Ying Shan; Gerard Tromp; Helena Kuivaniemi; Diane T Smelser; Shefali S Verma; Marylyn D Ritchie; James R Elmore; David J Carey; Yvette P Conley; Michael B Gorin; Daniel E Weeks
Journal:  Genet Epidemiol       Date:  2017-02-15       Impact factor: 2.135

Review 5.  Genetics of the extracellular matrix in aortic aneurysmal diseases.

Authors:  Chien-Jung Lin; Chieh-Yu Lin; Nathan O Stitziel
Journal:  Matrix Biol       Date:  2018-04-12       Impact factor: 11.583

Review 6.  Genetics of Thoracic and Abdominal Aortic Diseases.

Authors:  Amélie Pinard; Gregory T Jones; Dianna M Milewicz
Journal:  Circ Res       Date:  2019-02-15       Impact factor: 17.367

7.  Serum Sortilin Associates With Aortic Calcification and Cardiovascular Risk in Men.

Authors:  Claudia Goettsch; Hiroshi Iwata; Joshua D Hutcheson; Christopher J O'Donnell; Roland Chapurlat; Nancy R Cook; Masanori Aikawa; Pawel Szulc; Elena Aikawa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-03-09       Impact factor: 8.311

Review 8.  Vascular Genetics: Presentations, Testing, and Prognostics.

Authors:  Aaron W Aday; Sarah E Kreykes; Christina L Fanola
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-11-13

Review 9.  Abdominal aortic aneurysm: novel mechanisms and therapies.

Authors:  Frank M Davis; Debra L Rateri; Alan Daugherty
Journal:  Curr Opin Cardiol       Date:  2015-11       Impact factor: 2.161

10.  Replication of association of the apolipoprotein A1-C3-A4 gene cluster with the risk of gout.

Authors:  Humaira Rasheed; Amanda J Phipps-Green; Ruth Topless; Malcolm D Smith; Catherine Hill; Susan Lester; Maureen Rischmueller; Matthijs Janssen; Timothy L Jansen; Leo A Joosten; Timothy R Radstake; Philip L Riches; Anne-Kathrin Tausche; Frederic Lioté; Alexander So; Andre van Rij; Gregory T Jones; Sally P McCormick; Andrew A Harrison; Lisa K Stamp; Nicola Dalbeth; Tony R Merriman
Journal:  Rheumatology (Oxford)       Date:  2016-04-18       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.